eGVHD vs RBCX Calculation Tool

The “eGVHD App” is developed by the UZ Leuven (Belgium) in collaboration with the EBMT (European Bone Marrow Transplantation Society) Transplantation Complications Working Party and the National Institute of Health (Bethesda, USA). It is an electronic tool designed as an algorithm-driven application, to help clinicians apply the internationally recognized criteria for the assessment of graft versus host disease (GVHD), a pleiotropic disease affecting allogeneic stem cell transplantation recipients when their transplanted stem cells react against their own body. This app is not a medical tool aiming at replacing the diagnosis of a clinician, but a user-friendly educational tool. It helps health care professionals improve their ability to diagnose and score the severity of GVHD by showing the user differential information and it making an automatic summary of what has been filled in.

The Spectra Optia® Apheresis System RBCX Calculation Tool is intended to help medical professionals who are responsible for prescribing and performing red blood cell exchange (RBCX) procedures to estimate the volume of replacement fluid required to perform a procedure on the Spectra Optia system. Using the same patient data and the same fluid data that is entered on the Spectra Optia system, the RBCX Calculation Tool calculates and displays the estimated volume of replacement fluid required to achieve the target Hct and FCR. It can also determine whether a custom prime is recommended. While the tool is intended to help prepare for a procedure, it is not intended to be used for making medical decisions. Use of the Spectra Optia® Apheresis System RBCX Calculation Tool on iOS requires iOS version 14.0 or above. For more information about the tool, see the About page.